Lupin gets USFDA nod for Pitavastatin tablets Industry-The Economic Times — December 30, 2016 comments off The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market its Pitavastatin tablets.
The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market its Pitavastatin tablets.